Inventisbio Co., Ltd

This study is testing whether an experimental medication called D-2570 can help control symptoms of active psoriatic arthritis. Researchers will enroll 222 adults with the condition to compare different doses of the drug against a placebo over 12 weeks. The main goal is to see if…

This study is testing whether an investigational drug called D-2570 can safely and effectively clear skin lesions in people with moderate to severe plaque psoriasis. About 390 participants will be randomly assigned to receive either D-2570 or a placebo (an inactive substance) for…

This is an early, first-in-human study to check the safety of a new drug called D-2570. It will involve 36 healthy volunteers who will receive either the drug or a placebo (inactive pill) at different dose levels. The main goal is to see how safe the drug is and how the body abso…